{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:41:53Z","timestamp":1791607313501,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15H04913"],"award-info":[{"award-number":["15H04913"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The prognosis of hepatocellular carcinoma (HCC) with portal vein tumour thrombus (PVTT) is poor. We conducted a prospective study to evaluate the efficacy and safety of tri-modality therapy, including preoperative stereotactic body radiotherapy (SBRT) and surgery, followed by hepatic arterial infusion chemotherapy (HAIC) in HCC patients with PVTT. In this report, we investigated the pathology of the irradiated PVTT specimen in resected cases and SBRT-related acute toxicity. A total of 8 HCC patients with PVTT received preoperative SBRT targeting the PVTT at a dose of 48\u2009Gy\u2009in 4 fractions at our institute from 2012 to 2016. Of the eight patients, six underwent surgery, while the remaining two did not because of disease progression. At the pathological examination, all patients\u2019 irradiated PVTT specimens showed necrotic tissue, and three of six patients showed complete pathological response. Two patients showed 30% necrosis with high degeneration and one patient, with 30% necrosis without degeneration, was the only recurrent case found during the follow-up period (median: 22.5, range: 5.9\u201349.6 months). No SBRT-related acute toxicity worse than grade 2 was observed from SBRT to surgery. In conclusion, the preoperative SBRT for HCC was pathologically effective and the acute toxicities were tolerable.<\/jats:p>","DOI":"10.1038\/s41598-020-60871-0","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T11:06:26Z","timestamp":1583406386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Preoperative Stereotactic Body Radiotherapy to Portal Vein Tumour Thrombus in Hepatocellular Carcinoma: Clinical and Pathological Analysis"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5007-8808","authenticated-orcid":false,"given":"Noriko","family":"Kishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Kanayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takero","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigenori","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Nakatsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Marubashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Tomokuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruki","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"60871_CR1","unstructured":"Cancer Incidence in Five Continents, Vol. XI (electronic version). Lyon: International Agency for Research on Cancer. Available at: http:\/\/ci5.iarc.fr\/ (Accessed: 8th April 2019)."},{"key":"60871_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/hep.510290145","volume":"29","author":"JM Llovet","year":"1999","unstructured":"Llovet, J. M. et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 29, 62\u201367 (1999).","journal-title":"Hepatology."},{"key":"60871_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1053\/jhep.2000.9603","volume":"32","author":"E Villa","year":"2000","unstructured":"Villa, E. et al. Natural history of inoperable hepatocellular carcinoma: estrogen receptors\u2019 status in the tumor is the strongest prognostic factor for survival. Hepatology. 32, 233\u2013238 (2000).","journal-title":"Hepatology."},{"key":"60871_CR4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.surg.2004.12.012","volume":"137","author":"TM Pawlik","year":"2005","unstructured":"Pawlik, T. M. et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery. 137, 403\u2013410 (2005).","journal-title":"Surgery."},{"key":"60871_CR5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jamcollsurg.2005.11.012","volume":"202","author":"I Ikai","year":"2006","unstructured":"Ikai, I. et al. Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein. J. Am. Coll. Surg. 202, 431\u2013438 (2006).","journal-title":"J. Am. Coll. Surg."},{"key":"60871_CR6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s00268-013-2290-4","volume":"38","author":"KS Chok","year":"2014","unstructured":"Chok, K. S. et al. Surgical outcomes in hepatocellular carcinoma patients with portal vein tumor thrombosis. World. J. Surg. 38, 490\u2013496 (2014).","journal-title":"World. J. Surg."},{"key":"60871_CR7","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1399-0012.2009.01172.x","volume":"24","author":"ZX Wang","year":"2010","unstructured":"Wang, Z. X. et al. A single-center retrospective analysis of liver transplantation on 255 patients with hepatocellular carcinoma. Clin. Transplant. 24, 752\u2013757 (2010).","journal-title":"Clin. Transplant."},{"key":"60871_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2217\/hep.14.34","volume":"2","author":"KS Suh","year":"2015","unstructured":"Suh, K. S. & Lee, H. W. Liver transplantation for advanced hepatocellular carcinoma: how far can we go? Hepat. Oncol. 2, 19\u201328 (2015).","journal-title":"Hepat. Oncol."},{"key":"60871_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/lt.24782","volume":"23","author":"HJ Choi","year":"2017","unstructured":"Choi, H. J. et al. The clinical outcomes of patients with portal vein tumor thrombi after living donor liver transplantation. Liver. Transpl. 23, 1023\u20131031 (2017).","journal-title":"Liver. Transpl."},{"key":"60871_CR10","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1007\/s12032-011-0145-0","volume":"29","author":"ZJ Niu","year":"2012","unstructured":"Niu, Z. J. et al. Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification. Med. Oncol. 29, 2992\u20132997 (2012).","journal-title":"Med. Oncol."},{"key":"60871_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1245\/s10434-010-1321-8","volume":"18","author":"J Luo","year":"2011","unstructured":"Luo, J. et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study. Ann. Surg. Oncol. 18, 413\u2013420 (2011).","journal-title":"Ann. Surg. Oncol."},{"key":"60871_CR12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet, J. M. et al. Sorafenib in advanced hepatocellular carcinoma. N. Engl. J. Med. 359, 378\u2013390 (2008).","journal-title":"N. Engl. J. Med."},{"key":"60871_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","volume":"10","author":"AL Cheng","year":"2009","unstructured":"Cheng, A. L. et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet. Oncol. 10, 25\u201334 (2009).","journal-title":"Lancet. Oncol."},{"key":"60871_CR14","first-page":"971","volume":"30","author":"A Vogel","year":"2018","unstructured":"Vogel, A. et al. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 30, 971\u2013973 (2018).","journal-title":"Ann. Oncol."},{"key":"60871_CR15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/SLA.0b013e31818a07d4","volume":"248","author":"WC Chapman","year":"2008","unstructured":"Chapman, W. C. et al. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Ann. Surg. 248, 617\u2013625 (2008).","journal-title":"Ann. Surg."},{"key":"60871_CR16","first-page":"343","volume":"52","author":"H Wada","year":"2005","unstructured":"Wada, H. et al. Successful preoperative treatment for hepatocellular carcinoma with tumor thrombus in the major portal branch by three-dimensional conformal radiation therapy\u2013two case reports. Hepatogastroenterology 52, 343\u2013347 (2005).","journal-title":"Hepatogastroenterology"},{"key":"60871_CR17","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10147-007-0701-y","volume":"12","author":"T Kamiyama","year":"2007","unstructured":"Kamiyama, T. et al. Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinoma. Int. J. Clin. Oncol. 12, 363\u2013368 (2007).","journal-title":"Int. J. Clin. Oncol."},{"key":"60871_CR18","unstructured":"Marubashi, S., et al. A case of HCC with portal vein thrombosis treated with multidisciplinary treatment combined with preoperative SBRT and radical resection. Gan To Kagaku Ryoho 41, 2127\u20132129. Japanese (2014)."},{"key":"60871_CR19","unstructured":"Liver cancer study group of Japan. The general rules for the clinical and pathological study of primary liver cancer. 6th edition. (Kanehara & Co., Ltd (2015)."},{"key":"60871_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1477-2574.2010.00181.x","volume":"12","author":"JN Vauthey","year":"2010","unstructured":"Vauthey, J. N. et al. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford). 12, 289\u2013299 (2010).","journal-title":"HPB (Oxford)."},{"key":"60871_CR21","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","volume":"76","author":"CC Pan","year":"2010","unstructured":"Pan, C. C. et al. Radiation-associated liver injury. Int. J. Radiat. Oncol. Biol. Phys. 76, S94\u2013S100 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"60871_CR22","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00432-015-1974-6","volume":"141","author":"JM Straub","year":"2015","unstructured":"Straub, J. M. et al. Radiation-induced fibrosis: mechanisms and implications for therapy. J Cancer. Res. Clin. Oncol. 141, 1985\u20131994 (2015).","journal-title":"J Cancer. Res. Clin. Oncol."},{"key":"60871_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/jrr\/rru104","volume":"56","author":"SA Yeh","year":"2015","unstructured":"Yeh, S. A., Chen, Y. S. & Perng, D. S. The role of radiotherapy in the treatment of hepatocellular carcinoma with portal vein tumor thrombus. J. Radiat. Res. 56, 325\u2013331 (2015).","journal-title":"J. Radiat. Res."},{"key":"60871_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3346\/jkms.2009.24.2.242","volume":"24","author":"SB Choi","year":"2009","unstructured":"Choi, S. B. et al. The efficacy of hepatic resection after neoadjuvant transarterial chemoembolization (TACE) and radiation therapy in hepatocellular carcinoma greater than 5 cm in size. J. Korean. Med. Sci. 24, 242\u2013247 (2009).","journal-title":"J. Korean. Med. Sci."},{"key":"60871_CR25","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ijrobp.2013.07.022","volume":"88","author":"JM Brown","year":"2014","unstructured":"Brown, J. M. et al. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? Int. J. Radiat. Oncol. Biol. Phys. 88, 254\u2013262 (2014).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"60871_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-017-0899-4","volume":"12","author":"A Moore","year":"2017","unstructured":"Moore, A. et al. Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma. Radiat. Oncol. 12, 163 (2017).","journal-title":"Radiat. Oncol."},{"key":"60871_CR27","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.21037\/jgo.2017.08.11","volume":"8","author":"MM Rubinstein","year":"2017","unstructured":"Rubinstein, M. M. et al. Bridging therapy effectiveness in the treatment of hepatocellular carcinoma prior to orthotopic liver transplantation. J. Gastrointest. Oncol. 8, 1051\u20131055 (2017).","journal-title":"J. Gastrointest. Oncol."},{"key":"60871_CR28","first-page":"92","volume":"67","author":"G Sapisochin","year":"2017","unstructured":"Sapisochin, G. et al. Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis. J. Hepatol. 67, 92\u201399 (2017).","journal-title":"An intention-to-treat analysis. J. Hepatol."},{"key":"60871_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4240\/wjgs.v9.i12.256","volume":"9","author":"S Hasan","year":"2017","unstructured":"Hasan, S. et al. Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy. World. J. Gastrointest. Surg 9, 256\u2013263 (2017).","journal-title":"World. J. Gastrointest. Surg"},{"key":"60871_CR30","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","volume":"31","author":"A Bujold","year":"2013","unstructured":"Bujold, A. et al. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J. Clin. Oncol. 31, 1631\u20131639 (2013).","journal-title":"J. Clin. Oncol."},{"key":"60871_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3346\/jkms.2013.28.2.213","volume":"28","author":"SH Bae","year":"2013","unstructured":"Bae, S. H. et al. Feasibility and efficacy of stereotactic ablative radiotherapy for Barcelona Clinic Liver Cancer-C stage hepatocellular carcinoma. J. Korean. Med. Sci. 28, 213\u2013219 (2013).","journal-title":"J. Korean. Med. Sci."},{"key":"60871_CR32","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00535-011-0398-6","volume":"46","author":"S Komatsu","year":"2011","unstructured":"Komatsu, S. et al. The effectiveness of particle radiotherapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus. J. Gastroenterol. 46, 913\u2013920 (2011).","journal-title":"J. Gastroenterol."},{"key":"60871_CR33","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1002\/cncr.30816","volume":"123","author":"G Kasuya","year":"2017","unstructured":"Kasuya, G. et al. Progressive hypofractionated carbon-ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials. Cancer. 123, 3955\u20133965 (2017).","journal-title":"Cancer."},{"key":"60871_CR34","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/cncr.21237","volume":"104","author":"M Hata","year":"2005","unstructured":"Hata, M. et al. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer. 104, 794\u2013801 (2005).","journal-title":"Cancer."},{"key":"60871_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.rpor.2017.02.011","volume":"22","author":"H Doi","year":"2017","unstructured":"Doi, H. et al. Validation of the liver mean dose in terms of the biological effective dose for the prevention of radiation-induced liver damage. Rep. Pract. Oncol. Radiother. 22, 303\u2013309 (2017).","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"60871_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-9-18","volume":"9","author":"PM Wang","year":"2014","unstructured":"Wang, P. M. et al. Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients. Radiat. Oncol. 9, 18 (2014).","journal-title":"Radiat. Oncol."},{"key":"60871_CR37","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3109\/0284186X.2011.558522","volume":"50","author":"M Scorsetti","year":"2011","unstructured":"Scorsetti, M. et al. Stereotactic body radiation therapy for abdominal targets using volumetric intensity modulated arc therapy with RapidArc: feasibility and clinical preliminary results. Acta. Oncol. 50, 528\u2013538 (2011).","journal-title":"Acta. Oncol."},{"key":"60871_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4340-7","volume":"18","author":"Y Jeong","year":"2018","unstructured":"Jeong, Y. et al. Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma. BMC Cancer. 18, 416 (2018).","journal-title":"BMC Cancer."},{"key":"60871_CR39","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s00268-018-4829-x","volume":"43","author":"T Uemura","year":"2019","unstructured":"Uemura, T. et al. Stereotactic Body Radiation Therapy: A New Strategy for Loco-Regional Treatment for Hepatocellular Carcinoma While Awaiting Liver Transplantation. World. J. Surg. 43, 886\u2013893 (2019).","journal-title":"World. J. Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60871-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60871-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60871-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:11:46Z","timestamp":1670314306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60871-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["60871"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-60871-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]},"assertion":[{"value":"26 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4105"}}